mhra

MHRA publishes field safety notice list for 9–13 November 2026

MHRA’s list covers notices from eight manufacturers involving navigation software, implants, laboratory products and care equipment.

Eren İŞMANMDR Auditor
Türkçe oku
Conceptual regulatory safety illustration linking medical devices with field safety notice documents
AI-generated conceptual illustration, not a photograph of an actual event.

What Changed

The UK Medicines and Healthcare products Regulatory Agency (MHRA) published its field safety notice list for 9–13 November 2026 on 17 November 2026. It brings together notices from eight manufacturers across several medical-device and laboratory product groups.

MHRA states that the list is published for information only. It emphasises that anyone receiving a field safety notice (FSN) from a manufacturer must always act on it.

Who Is Affected

The list includes Boston Scientific’s Vercise Neural Navigator 5 Software and Brainlab’s Navigation Software Cranial EM electromagnetic surgical navigation/tracking system. The Brainlab entry identifies models 2240-06, 22240-06B, 22240-06C, 22240-06D, 22240-06E, 22240-06F, 22240-06G and 22240-06H.

Medtronic’s Vanta with AdaptiveStim Technology appears under model 977006 and reference FA1340, with the entry marked as a November 2026 update. NINGBO GAOBO SPORTS’ VivaLife Easy Up Cane is also listed.

Laboratory products include Ortho-Clinical Diagnostics’ VITROS Chemistry Products A1c Slides and Siemens Healthcare’s Atellica CH Analyzer and Atellica CI Analyzer.

The remaining entries concern Raz Design’s Raz Mobile Shower Commode Chair models Raz-AT (Z300), Raz-ART (Z333), Raz-SP (Z200) and ZUM-SP (Z222), and Sterisets’ Steriflush Syringes with water.

Regulatory and Technical Implications

The MHRA listing identifies products, selected model details and notice references. It does not describe device-specific hazards, affected lot or serial numbers, or technical corrective steps.

The entries therefore cannot be treated as evidence of a shared risk or a uniform response. The list alone does not establish that every product requires a recall, suspension of use or software change.

Manufacturer Actions

The announcement does not establish a new, common action timetable for manufacturers. MHRA’s explicit direction is for recipients to act on the relevant FSN and contact the manufacturer with questions about a particular notice.

Device-specific action should be determined from the relevant manufacturer’s notice; the weekly listing does not replace detailed implementation instructions.

Confirmed Dates

The list was published and issued on 17 November 2026, while its title covers 9–13 November 2026. Individual notice dates can precede that reporting period.

The Boston Scientific entry is dated 6 November; Brainlab, 22 October; NINGBO GAOBO SPORTS, 20 October; Raz Design, 4 November; and Sterisets, 12 October 2026. Medtronic’s entry specifies November 2026, and Siemens Healthcare’s specifies September 2026. No individual notice date is stated for Ortho-Clinical Diagnostics. The list does not specify action-completion deadlines.

Official Source

MHRA, GOV.UK: “Field Safety Notices: 9 to 13 November 2026”.

Https://www.gov.uk/drug-device-alerts/field-safety-notices-9-to-13-november-2026

Source and related services

Field Safety Notices: 9 to 13 November 2026 ↗

Source date: 17/11/2026

This news provides general information and does not replace device-specific legal or conformity assessment advice.

Related news

MHRA sets out 2026–2027 clinical investigation fee waivers →MHRA awards ILAP Innovation Passports to three investigational treatments →MHRA publishes second-quarter results report for 2026–2027 →
Contact an MDR Expert